Accession Number:

AD1041711

Title:

Pyridostimine Bromide 30mg Stability in Extended Storage Conditions

Personal Author(s):

Corporate Author:

59th Medical Wing San Antonio United States

Report Date:

2017-12-03

Abstract:

Pyridostigmine bromide 30mg is approved by the Federal Drug Administration FDA as a pre-treatment of nerve gas exposure. The package insert specifiespyridostigmine needs to be refrigerated while stored and discarded three months after removal from the fridge and dispensing. The objective of this study is to determine the stability of pyridostigmine under extended storage conditions.

Descriptive Note:

Conference Paper

Supplementary Note:

American Society of Health-System Pharmacists , 03 Dec 2017, 07 Dec 2017,

Pages:

0003

Descriptors:

Identifiers:

Subject Categories:

Communities Of Interest:

Distribution Statement:

Approved For Public Release;

File Size:

1.37MB

View The Document